KRYS
Price
$169.56
Change
-$1.01 (-0.59%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
4.91B
6 days until earnings call
UTHR
Price
$303.09
Change
+$2.33 (+0.77%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
13.51B
90 days until earnings call
Ad is loading...

KRYS vs UTHR

Header iconKRYS vs UTHR Comparison
Open Charts KRYS vs UTHRBanner chart's image
Krystal Biotech
Price$169.56
Change-$1.01 (-0.59%)
Volume$3.03K
Capitalization4.91B
United Therapeutics
Price$303.09
Change+$2.33 (+0.77%)
Volume$11.85K
Capitalization13.51B
KRYS vs UTHR Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. UTHR commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a StrongBuy and UTHR is a Buy.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (KRYS: $170.57 vs. UTHR: $300.76)
Brand notoriety: KRYS and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 87% vs. UTHR: 108%
Market capitalization -- KRYS: $4.91B vs. UTHR: $13.51B
KRYS [@Biotechnology] is valued at $4.91B. UTHR’s [@Biotechnology] market capitalization is $13.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 7 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • KRYS’s TA Score: 7 bullish, 3 bearish.
  • UTHR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than UTHR.

Price Growth

KRYS (@Biotechnology) experienced а +1.05% price change this week, while UTHR (@Biotechnology) price change was +2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.93%. For the same industry, the average monthly price growth was +3.53%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

UTHR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+2.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.5B) has a higher market cap than KRYS($4.91B). KRYS has higher P/E ratio than UTHR: KRYS (56.86) vs UTHR (12.21). KRYS YTD gains are higher at: 8.879 vs. UTHR (-14.760). UTHR has higher annual earnings (EBITDA): 1.65B vs. KRYS (110M). UTHR has more cash in the bank: 3.27B vs. KRYS (598M). KRYS has less debt than UTHR: KRYS (7.26M) vs UTHR (300M). UTHR has higher revenues than KRYS: UTHR (2.88B) vs KRYS (291M).
KRYSUTHRKRYS / UTHR
Capitalization4.91B13.5B36%
EBITDA110M1.65B7%
Gain YTD8.879-14.760-60%
P/E Ratio56.8612.21466%
Revenue291M2.88B10%
Total Cash598M3.27B18%
Total Debt7.26M300M2%
FUNDAMENTALS RATINGS
KRYS vs UTHR: Fundamental Ratings
KRYS
UTHR
OUTLOOK RATING
1..100
920
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
1923
SMR RATING
1..100
6747
PRICE GROWTH RATING
1..100
5559
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTHR's Valuation (68) in the Pharmaceuticals Other industry is in the same range as KRYS (79) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (19) in the Pharmaceuticals Major industry is in the same range as UTHR (23) in the Pharmaceuticals Other industry. This means that KRYS’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's SMR Rating (47) in the Pharmaceuticals Other industry is in the same range as KRYS (67) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Price Growth Rating (55) in the Pharmaceuticals Major industry is in the same range as UTHR (59) in the Pharmaceuticals Other industry. This means that KRYS’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's P/E Growth Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for KRYS (100) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew somewhat faster than KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSUTHR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 23 days ago
76%
Bearish Trend 10 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ISD13.580.22
+1.65%
PGIM High Yield
BRAZ23.050.15
+0.64%
Global X Brazil Active ETF
XDSQ34.560.17
+0.50%
Innovator US Eq Acltd ETF™ Quarterly
HTRB33.770.09
+0.26%
Hartford Total Return Bond ETF
SDCI20.64-0.25
-1.20%
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+0.49%
ACLX - KRYS
55%
Loosely correlated
+0.25%
IDYA - KRYS
51%
Loosely correlated
-0.25%
CRNX - KRYS
50%
Loosely correlated
+0.60%
ROIV - KRYS
49%
Loosely correlated
+0.89%
CGON - KRYS
48%
Loosely correlated
-3.68%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+1.25%
DAWN - UTHR
40%
Loosely correlated
-0.78%
TECH - UTHR
38%
Loosely correlated
+0.50%
GERN - UTHR
37%
Loosely correlated
-1.43%
KRYS - UTHR
35%
Loosely correlated
+0.49%
HALO - UTHR
35%
Loosely correlated
+0.41%
More